- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04963543
Evaluation of Comfort in Symptomatic Contact Lens Wearers
November 2, 2021 updated by: Alcon Research
The purpose of this study is to evaluate the comfort of an ocular lubricant in symptomatic contact lens wearers.
This study will be conducted in Canada.
Study Overview
Detailed Description
The duration of individual participation is six days.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Alcon Investigative Site 6189
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Key Inclusion Criteria:
- Is able to understand and sign an approved information consent letter;
- Habitually wears daily disposable soft contact lenses in both eyes;
- Is able to achieve 20/40 or better monocular VA with habitual contact lenses;
- Has a pair of spectacles for vision correction.
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria:
- Routinely sleeps in habitual contact lenses;
- Has any known active ocular disease and/or infection;
- Is pregnant or lactating;
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FID123238
FID123238 applied to the ocular surface, 1 application per day, for five consecutive days
|
Lubricant applied to the ocular surface
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort, collected for each eye
Time Frame: Up to Day 6
|
A visual analogue scale will be used
|
Up to Day 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Clinical Trial Lead, Dry Eye, Alcon Research, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 22, 2021
Primary Completion (Actual)
October 29, 2021
Study Completion (Actual)
October 29, 2021
Study Registration Dates
First Submitted
July 6, 2021
First Submitted That Met QC Criteria
July 6, 2021
First Posted (Actual)
July 15, 2021
Study Record Updates
Last Update Posted (Actual)
November 3, 2021
Last Update Submitted That Met QC Criteria
November 2, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- DEJ475-E003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ocular Comfort
-
CIBA VISIONBascom Palmer Eye InstituteCompletedOcular ComfortUnited States
-
Laboratorios Sophia S.A de C.V.CompletedTolerability | Safety | Ocular Surface | Ocular ComfortMexico
-
Bausch & Lomb IncorporatedCompleted
-
National Center for Occupational Health and Infection...VA Office of Research and DevelopmentCompletedTolerability | ComfortUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Ohio State UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Completed
-
Izmir Katip Celebi UniversityRecruitingComfort | Vital Sign MonitoringTurkey
-
Karabuk UniversityCompletedMentoring | Comfort | Medication AdministrationTurkey
-
GE Healthcarei3 StatprobeCompletedPatient Comfort and SafetyUnited States
-
Funda Kardas OzdemirCompletedStress | ComfortTurkey (Türkiye)
Clinical Trials on FID123238
-
Alcon ResearchCompleted